During the past decade, The First Affiliated Hospital of Chongqing Medical University conducted 158 clinical trials. In the 10-year time frame, 158 clinical trials started and 9 clinical trials were completed, i.e. on average, 5.7% percent of trials that started reached the finish line to date. In the past 5 years, 107 clinical trials started and 8 clinical trials were completed. i.e. 7.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Affiliated Hospital of Chongqing Medical University" #1 sponsor was "Chongqing Medical University" with 39 trials, followed by "First Affiliated Hospital of Chongqing Medical University" with 17 trials sponsored, "Eli Lilly and Company" with 10 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored and "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 6 trials sponsored. Other sponsors include 95 different institutions and companies that sponsored additional 81 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital of Chongqing Medical University" #1 collaborator was "First Affiliated Hospital of Chongqing Medical University" with 7 trials as a collaborator, "Henan Provincial People's Hospital" with 3 trials as a collaborator, "Peking Union Medical College Hospital" with 3 trials as a collaborator, "Peking University First Hospital" with 3 trials as a collaborator and "The Second Hospital of Hebei Medical University" with 3 trials as a collaborator. Other collaborators include 161 different institutions and companies that were collaborators in the rest 150 trials.

According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital of Chongqing Medical University" are "Heart Failure With Preserved Ejection Fraction" (9 trials), "Primary Aldosteronism" (6 trials), "Alzheimer Disease" (4 trials), "Type 2 Diabetes" (4 trials) and "Ulcerative Colitis" (4 trials). Many other conditions were trialed in "The First Affiliated Hospital of Chongqing Medical University" in a lesser frequency.

Most popular intervention types in "The First Affiliated Hospital of Chongqing Medical University" are "Drug" (103 trials), "Device" (16 trials), "Procedure" (12 trials), "Other" (10 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Cisplatin" (5 trials), "Pembrolizumab" (4 trials), "Carboplatin" (3 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "The First Affiliated Hospital of Chongqing Medical University" are 167 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 87 active trials in "The First Affiliated Hospital of Chongqing Medical University". 3 are not yet recruiting, 65 are recruiting, 15 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 49 completed trials in The First Affiliated Hospital of Chongqing Medical University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The First Affiliated Hospital of Chongqing Medical University, 4 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 28 trials that are defined as “Not Applicable".

The First Affiliated Hospital of Chongqing Medical University has several departments that took part in Clinical trials: "Children's Hospital of Chongqing Medical University" - 60 trials